MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Jan 22, 2019
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Tax Payment
Common Stock, par value $0.00001 per share
2019-01-19$8.78/sh−2,044$17,946→ 91,991 total
Footnotes (1)
- [F1]These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations upon the vesting of certain shares of restricted stock units.